Link Pharma Chem Complete Financial Statements
In FY2026, Link Pharma Chem (LINKPH) reported revenue ₹27 Cr, net profit ₹0 Cr and EPS ₹0.17. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Also explore LINKPH stock price history to track price trends across different timeframes.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
LINKPH Revenue, Net Profit & EBITDA — Year-on-Year Growth
LINKPH YoY (March 2025 vs March 2026) — revenue +3.8%, net profit +100.0%, expenses +4.0%. Analyse LINKPH shareholding pattern to track promoter, FII and institutional holdings.
LINKPH Income Statement — Revenue, EBITDA & Net Profit
Link Pharma Chem revenue ₹27 Cr, EBITDA ₹1 Cr, net profit ₹0 Cr, EPS ₹0.17 (2026). For live price, earnings ratios and company overview, see Link Pharma Chem share price screener.
| Particulars | March 2026 | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 27 | 26 | 31 | 39 | 54 | 35 | 26 | 25 | 24 | 16 | 15 | 18 |
| Expenses | 26 | 25 | 31 | 36 | 50 | 32 | 23 | 23 | 21 | 14 | 13 | 18 |
| EBITDA | 1 | 0 | 0 | 3 | 4 | 3 | 3 | 2 | 3 | 2 | 3 | -1 |
| Operating Profit Margin % | 5.00% | 1.00% | -2.00% | 7.00% | 7.00% | 9.00% | 10.00% | 8.00% | 12.00% | 13.00% | -1.00% | -4.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 0 | -1 | -2 | 1 | 3 | 2 | 1 | 1 | 1 | 1 | 1 | -3 |
| Tax | 0 | 0 | -1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | -1 |
| Net Profit | 0 | -1 | -1 | 1 | 2 | 1 | 1 | 1 | 1 | 0 | 1 | -2 |
| Earnings Per Share (₹) | 0.17 | -2.31 | -3.07 | 1.47 | 4.24 | 2.44 | 2.14 | 1.48 | 2.56 | 0.51 | 1.33 | -4.94 |
LINKPH Balance Sheet — Assets, Liabilities & Shareholders' Equity
LINKPH total assets ₹25 Cr, total equity ₹13 Cr, total liabilities ₹ Cr (2026).
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| Total Assets | 25 | 23 | 26 | 33 | 29 | 26 | 19 | 18 | 17 | 17 | 18 | 27 |
| Current Assets | 11 | 11 | 12 | 18 | 14 | 15 | 9 | 7 | 7 | 7 | 7 | 8 |
| Fixed Assets | 10 | 9 | 10 | 9 | 9 | 9 | 9 | 9 | 10 | 10 | 10 | 18 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 5 | 2 | 3 | 4 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 12 | 13 | 20 | 15 | 17 | 10 | 8 | 7 | 8 | 8 | 9 |
| LIABILITIES | ||||||||||||
| Total Liabilities | ||||||||||||
| Current Liabilities | 1 | 1 | 1 | 3 | 4 | 4 | 4 | 3 | 3 | 2 | 2 | 9 |
| Non-Current Liabilities | ||||||||||||
| SHAREHOLDERS' EQUITY | ||||||||||||
| Total Equity | 13 | 13 | 14 | 15 | 15 | 13 | 11 | 10 | 10 | 9 | 9 | 8 |
| Share Capital | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Reserves & Surplus | 8 | 8 | 9 | 11 | 10 | 8 | 7 | 6 | 5 | 4 | 5 | 4 |
LINKPH Cash Flow Statement — Operating, Investing & Financing
Link Pharma Chem operating cash flow ₹3 Cr, investing ₹2 Cr, financing ₹-4 Cr, net cash flow ₹0 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 3 | 0 | -2 | -1 | 5 | 3 | 1 | 4 | 2 | -4 | 5 |
| Investing Activities | 2 | 0 | 0 | -5 | -2 | -2 | -1 | -1 | -1 | 9 | -3 |
| Financing Activities | -4 | 0 | 2 | 2 | 0 | 1 | -1 | -3 | -2 | -6 | -1 |
| Net Cash Flow | 0 | 0 | 0 | -4 | 2 | 2 | 0 | 0 | 0 | -1 | 1 |